You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 4701 to 4725 of about 5967
Next 25
10/19/2005
Brain cancer patients fight an unseen enemy Advice and updated information offered at recent area conference
November 13th Brain Tumor Awareness Day: PurpleTrunk, The Brain Tumor Foundation and David Craig Welch Form an Alliance to Focus on Education, Early Detection and Fund Raising
Oncolytics Biotech Inc. Ends Patient Treatment in Canadian Phase I Recurrent Malignant Glioma Clinical Trial
NeoPharm Investigators Present Preliminary Phase I Data of Cintredekin Besudotox in the Treatment of Malignant Glioma at Initial Diagnosis
10/18/2005
Autumn Birth Linked to Childhood Brain Cancer
O6–BG May Help Re-Sensitize Cancer Cells to Temodar® in Brain Cancer
10/14/2005
Support Group for Parents of children with brain tumors (NY)
The Guardian Brain Foundation 3rd annual Butterfly Ball
10/06/2005
Attacking Brain Cancer At Tumor Site Extends Survival
10/05/2005
NEOPHARM ANNOUNCES CINTREDEKIN BESUDOTOX POSTER PRESENTATION AT 55TH ANNUAL MEETING OF THE CONGRESS OF NEUROLOGICAL SURGEONS
The National Brain Tumor Foundation and the Brain Tumor Society are teaming up to provide a web conference on rehabilitation for brain tumor patients.
Phase I trial of temozolomide plus o6-benzylguanine for patients with recurrent or progressive malignant glioma.
The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic - perspective.
Molecular biology of medulloblastoma: will it ever make a difference to clinical management?
Considerations on the Role of Chemotherapy and Modern Radiotherapy in the Treatment of Childhood Low Grade Glioma.
Molecularly Targeted Therapy for Pediatric Brain Tumors.
Results of a Survey of Neurosurgical Practice Patterns Regarding the Prophylactic use of Anti-Epilepsy Drugs in Patients with Brain Tumors.
Stereotactically Guided Fractionated Re-irradiation in Recurrent Glioblastoma Multiforme.
Prolonged oral hydroxyurea and concurrent 3d-conformal radiation in patients with progressive or recurrent meningioma: results of a pilot study.
Inactivation of p53 Sensitizes Astrocytic Glioma Cells to BCNU and Temozolomide, but not Cisplatin.
Irinotecan (CPT-11) Therapy in a 12-year-old Girl with Recurrent Brain Stem Glioma and without Functional Polymorphisms in UGT1A1 Activity: Case Report.
Inhibition of glioma cell proliferation by neural stem cell factor.
Arachnoid cysts cause cognitive deficits that improve after surgery.
Chemoradiotherapy for primary CNS lymphoma: an intent-to-treat analysis with complete follow-up.
Role of stereotactic radiosurgery as a primary treatment option in the management of newly diagnosed multiple (3-6) intracranial metastases.